XTRA:AFXMedical Equipment
Assessing Carl Zeiss Meditec (XTRA:AFX) Valuation After Weak Earnings And New Profit Up Restructuring Plan
Carl Zeiss Meditec (XTRA:AFX) reported weaker second quarter and first half 2025/2026 results, with lower sales and net income, and introduced its multi year Profit Up restructuring program targeting more than €200 million in annual profit improvements.
See our latest analysis for Carl Zeiss Meditec.
Despite the weak first half, the share price has reacted sharply in the short term, with a 1 day share price return of 12.36% and a 30 day share price return of 10.72%, while the 1 year total...